CTXR logo

Citius Pharmaceuticals (CTXR) Company Overview

Profile

Full Name:

Citius Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 2, 2014

Indexes:

Not included

Description:

Citius Pharmaceuticals (CTXR) is a biopharmaceutical company focused on developing innovative therapies for critical care and cancer patients. They aim to improve treatment options and outcomes through advanced drug formulations and delivery systems, addressing unmet medical needs in the healthcare market.

Events Calendar

Earnings

Next earnings date:

May 14, 2025

Recent quarterly earnings:

Feb 14, 2025

Recent annual earnings:

Dec 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 26, 2024

Analyst ratings

Recent major analysts updates

Feb 18, 25 D. Boral Capital
Buy
Jan 7, 25 D. Boral Capital
Buy
Dec 30, 24 D. Boral Capital
Buy
Nov 22, 24 D. Boral Capital
Hold
Nov 12, 24 HC Wainwright & Co.
Buy
Nov 11, 24 D. Boral Capital
Buy
Aug 19, 24 EF Hutton
Buy
Aug 8, 24 EF Hutton
Buy
Aug 5, 24 EF Hutton
Buy
Jul 15, 24 EF Hutton
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Citius Pharmaceuticals?
  • Does Citius Pharmaceuticals pay dividends?
  • What sector is Citius Pharmaceuticals in?
  • What industry is Citius Pharmaceuticals in?
  • What country is Citius Pharmaceuticals based in?
  • When did Citius Pharmaceuticals go public?
  • Is Citius Pharmaceuticals in the S&P 500?
  • Is Citius Pharmaceuticals in the NASDAQ 100?
  • Is Citius Pharmaceuticals in the Dow Jones?
  • When was Citius Pharmaceuticals's last earnings report?
  • When does Citius Pharmaceuticals report earnings?
  • Should I buy Citius Pharmaceuticals stock now?

What is the ticker symbol for Citius Pharmaceuticals?

The ticker symbol for Citius Pharmaceuticals is NASDAQ:CTXR

Does Citius Pharmaceuticals pay dividends?

No, Citius Pharmaceuticals does not pay dividends

What sector is Citius Pharmaceuticals in?

Citius Pharmaceuticals is in the Healthcare sector

What industry is Citius Pharmaceuticals in?

Citius Pharmaceuticals is in the Biotechnology industry

What country is Citius Pharmaceuticals based in?

Citius Pharmaceuticals is headquartered in United States

When did Citius Pharmaceuticals go public?

Citius Pharmaceuticals's initial public offering (IPO) was on October 2, 2014

Is Citius Pharmaceuticals in the S&P 500?

No, Citius Pharmaceuticals is not included in the S&P 500 index

Is Citius Pharmaceuticals in the NASDAQ 100?

No, Citius Pharmaceuticals is not included in the NASDAQ 100 index

Is Citius Pharmaceuticals in the Dow Jones?

No, Citius Pharmaceuticals is not included in the Dow Jones index

When was Citius Pharmaceuticals's last earnings report?

Citius Pharmaceuticals's most recent earnings report was on Feb 14, 2025

When does Citius Pharmaceuticals report earnings?

The next expected earnings date for Citius Pharmaceuticals is May 14, 2025

Should I buy Citius Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions